Stephen Klincewicz

Stephen Klincewicz is an accomplished professional in drug safety and pharmacovigilance with extensive experience across various prominent organizations. Currently serving as Senior Director and Head of Patient Safety at Formation Bio since April 2022, Stephen previously held key leadership roles, including Vice President of Drug Safety and Pharmacovigilance at Finch Therapeutics and Vice President Global Drug Safety at Precision For Medicine. Stephen's expertise includes global pharmacovigilance for stem cell therapy products during tenure at Mesoblast Inc. and comprehensive product vigilance for multiple product categories at Bayer Consumer Care. Prior roles encompass significant positions at Johnson and Johnson and Astra Zeneca, alongside earlier clinical practice as an Occupational Health Physician and a background in public health as an Epidemic Intelligence Service Officer. Stephen's educational credentials include degrees in Medicine, Public Health, and Law, as well as advanced executive education from prestigious institutions such as the Saïd Business School at the University of Oxford and Harvard Business School.